Beth L. Laube

4.7k total citations · 1 hit paper
92 papers, 3.4k citations indexed

About

Beth L. Laube is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Beth L. Laube has authored 92 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 30 papers in Physiology and 8 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Beth L. Laube's work include Inhalation and Respiratory Drug Delivery (45 papers), Asthma and respiratory diseases (28 papers) and Cystic Fibrosis Research Advances (23 papers). Beth L. Laube is often cited by papers focused on Inhalation and Respiratory Drug Delivery (45 papers), Asthma and respiratory diseases (28 papers) and Cystic Fibrosis Research Advances (23 papers). Beth L. Laube collaborates with scholars based in United States, Australia and Hungary. Beth L. Laube's co-authors include Richard N. Dalby, Ildikó Horváth, Frans H. de Jongh, Julie Suman, Sunalene G. Devadason, Hettie M. Janssens, Paolo Navalesi, Henry Chrystyn, P. Diot and Mark L. Everard and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Beth L. Laube

91 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What the pulmonary specialist should know about the new inhalation therapies

2011 584 citations Beth L. Laube, Sunalene G. Devadason et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth L. Laube United States	33	2.7k	1.3k	250	243	222	92	3.4k
S W Clarke United Kingdom	41	4.2k 1.6×	2.0k 1.5×	332 1.3×	196 0.8×	207 0.9×	155	5.2k
Michael T. Newhouse Canada	46	4.6k 1.7×	2.2k 1.6×	509 2.0×	118 0.5×	216 1.0×	147	5.9k
P. Diot France	35	3.2k 1.2×	984 0.7×	313 1.3×	234 1.0×	317 1.4×	173	4.5k
Evangelia Daviskas Australia	31	2.6k 1.0×	1.3k 1.0×	66 0.3×	110 0.5×	85 0.4×	52	3.0k
Richard N. Dalby United States	25	1.2k 0.5×	366 0.3×	168 0.7×	356 1.5×	146 0.7×	46	1.7k
Bruce K. Rubin United States	28	2.1k 0.8×	709 0.5×	208 0.8×	131 0.5×	116 0.5×	65	2.6k
David E. Geller United States	35	3.7k 1.4×	789 0.6×	131 0.5×	229 0.9×	181 0.8×	79	4.3k
D Pavia United Kingdom	31	3.0k 1.1×	1.3k 1.0×	153 0.6×	94 0.4×	121 0.5×	118	3.5k
Laurent Vecellio France	29	1.6k 0.6×	257 0.2×	114 0.5×	253 1.0×	277 1.2×	101	2.2k
Stephen P. Newman United Kingdom	45	5.1k 1.9×	2.4k 1.8×	68 0.3×	636 2.6×	499 2.2×	101	5.9k

Countries citing papers authored by Beth L. Laube

Since Specialization

Citations

This map shows the geographic impact of Beth L. Laube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth L. Laube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth L. Laube more than expected).

Fields of papers citing papers by Beth L. Laube

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth L. Laube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth L. Laube. The network helps show where Beth L. Laube may publish in the future.

Co-authorship network of co-authors of Beth L. Laube

This figure shows the co-authorship network connecting the top 25 collaborators of Beth L. Laube. A scholar is included among the top collaborators of Beth L. Laube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth L. Laube. Beth L. Laube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laube, Beth L., et al.. (2024). Climate Policy and Pediatric Asthma: How Transition to Nonhydrofluorocarbon Propellants Will Disproportionately Impact Children. Annals of the American Thoracic Society. 21(9). 1242–1244. 5 indexed citations

Donaldson, Scott H., Timothy E. Corcoran, Joseph M. Pilewski, et al.. (2023). Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis. Journal of Cystic Fibrosis. 23(1). 155–160. 14 indexed citations

Kesavan, Jana, et al.. (2023). Effect of Age and Head Position on Total and Regional Aerosol Deposition in Three-Dimensional Models of Human Intranasal Airways Using a Mucosal Atomization Device. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 36(3). 89–100. 2 indexed citations

Donaldson, Scott H., Beth L. Laube, Peter J. Mogayzel, et al.. (2021). Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study. Journal of Cystic Fibrosis. 21(1). 143–145. 16 indexed citations

Laube, Beth L., et al.. (2019). Mucociliary Clearance in Former Tobacco Smokers with Both Chronic Obstructive Pulmonary Disease and Chronic Bronchitis and the Effect of Roflumilast. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 189–199. 3 indexed citations

Bennett, William D., Kirby L. Zeman, Beth L. Laube, et al.. (2017). Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(4). 204–211. 5 indexed citations

Phillips, Yancy Y., James J. Jaeger, Beth L. Laube, & Richard R. Rosenthal. (2015). Eucapnic Voluntary Hyperventilation of Compressed Gas Mixture. American Review of Respiratory Disease. 1 indexed citations

Laube, Beth L., et al.. (2015). Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(5). 320–333. 17 indexed citations

Fahy, Bonnie, et al.. (2014). Using Your Metered Dose Inhaler (MDI). American Journal of Respiratory and Critical Care Medicine. 190(8). P5–P6. 8 indexed citations

10.

Newman, Stephen P., William D. Bennett, Martyn F. Biddiscombe, et al.. (2012). Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(S1). S–10. 85 indexed citations

11.

Fleming, John, Dale L. Bailey, Hak‐Kim Chan, et al.. (2012). Standardization of Techniques for Using Single-Photon Emission Computed Tomography (SPECT) for Aerosol Deposition Assessment of Orally Inhaled Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(S1). S–29. 32 indexed citations

12.

Bhashyam, Abhiram R., Peter J. Mogayzel, Sharon A. McGrath‐Morrow, et al.. (2012). A Pilot Study to Examine the Effect of Chronic Treatment with Immunosuppressive Drugs on Mucociliary Clearance in a Vagotomized Murine Model. PLoS ONE. 7(9). e45312–e45312. 9 indexed citations

13.

Rosenberg, Yvonne J., et al.. (2012). Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques. Chemico-Biological Interactions. 203(1). 167–171. 22 indexed citations

14.

Laube, Beth L., et al.. (2005). Positive Expiratory Pressure Changes Aerosol Distribution in Patients With Cystic Fibrosis. Respiratory Care. 50(11). 1438–1444. 35 indexed citations

15.

Laube, Beth L.. (1998). Measurement of aerosol deposition in CF. Pediatric Pulmonology. 26. 181–182. 1 indexed citations

16.

Laube, Beth L., et al.. (1996). Effect of rhDNase on Airflow Obstruction and Mucociliary Clearance in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 153(2). 752–760. 54 indexed citations

17.

Laube, Beth L., et al.. (1993). Acute Exposure to Acid Fog: Effects on Mucociliary Clearance. American Review of Respiratory Disease. 147(5). 1105–1111. 17 indexed citations

18.

Laube, Beth L., Philip S. Norman, & G. K. Adams. (1992). The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. Journal of Allergy and Clinical Immunology. 89(2). 510–518. 42 indexed citations

19.

Rosenthal, Richard R., et al.. (1990). Analysis of Refractory Period after Exercise and Eucapnic Voluntary Hyperventilation Challenge. American Review of Respiratory Disease. 141(2). 368–372. 18 indexed citations

20.

Laube, Beth L., Jonathan M. Links, Norman LaFrance, Henry N. Wagner, & Beryl J. Rosenstein. (1989). Homogeneity of Bronchopulmonary Distribution of 99mTc Aerosol in Normal Subjects and in Cystic Fibrosis Patients. CHEST Journal. 95(4). 822–830. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact